Maryland · Nonprofit
AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED
AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED (Maryland) receives grants from 3 organizations whose IRS filings report $7,521 to it, the largest being VISITOR DEVELOPMENT FUND INC ($7,000). 1 of them have funded it in more than one year.
- Revenue FY2024
- $6.7M
- Funders on record
- 3
- Grants received
- $8k
- Net assets
- $27M
What American Society for Pharmacology & Experimental Therapeutics Incorporated does
Mission
The american society for pharmacology and experimental therapeutics (aspet) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations.
As stated on its FY2024 Form 990.
Programs
Publications - the society publishes scientific and educational journals and other publications for the scientific community including the following:journal of pharmacology and experimental therapeutics - monthly research publication covering topics including the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.pharmacological reviews - quarterly review journal covering concentrations in pharmacology, experimental therapeutics, toxicology, and chemotherapy.molecular pharmacology - monthly publication with an emphasis on research of drug action and selective toxicity at the molecular level. Original applications of biochemistry, biophysics, genetics and molecular biology are combined with pharmacologic research to solve basic problems in pharmacology and toxicology.drug metabolism and disposition - monthly publication covering the fields of pharmacokinetics, pharmacodynamics and mechanisms, genetic nutritional or hormonal factors affecting…
$1,918,957 spent$3,370,443 earned by the program33% of program spendingMeetings - the society hosts an annual meeting each year in a different part of the us providing a forum for scientists to communicate and exchange pharmacological knowledge through scientific sessions. Smaller focused meetings are held on an occasional basis as the need arises.
$1,575,137 spent$470,060 earned by the program27% of program spendingMarketing - to promote aspet's programs and services, produce the pharmacologist, aspet's monthly newsletter, promote memberships and the annual meeting.
$596,559 spent10% of program spendingAwards - the society offers three types of awards to distinguished pharmacologists and to students and young scientists in the field. Scientific awards are provided to recognize and encourage outstanding research by prominent pharmacologists and to stimulate fundamental research by young investigators. Best poster awards are presented to meeting attendees who have submitted an outstanding research abstract for presentation at the meeting. Travel awards are granted to students as an educational tool to attend scientific meetings.
$579,747 spentof which $276,000 as grants10% of program spendingMember services - includes membership communications and divisions to address specific areas of concern or interest to the member pharmacologists in the society. Nomination and election of new members, development of educational activities relevant to the promotion and advancement of the scientific discipline. Web site provides an interface between members and the society as well as information to individuals wishing to learn more about the field of pharmacology.
$552,436 spent$352,525 earned by the program10% of program spendingPublic services - provides information to the general public about pharmacology and scientific achievements and needs in the field. Officers and members provide a resource to the community when there is a need for specialized expertise. The education division conducts special sessions devoted to improving education in the pharmacological sciences.
$314,752 spent5% of program spendingEducational affairs - supports summer undergraduate research fellowships in the field of pharmacology.
$260,133 spent4% of program spending
The 7 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $5,797,721.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $23M to $27M (+21%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 5%. Grants only. Government contracts and fees sit inside program revenue.
0% of AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED’s revenue is contributions — more earned-revenue than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2020 → 2023: the base narrowed from 2 funders to 1 funder, grant income fell $306 → $51.
1 of 3 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 4% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED leans on a few funders — its largest provides 93% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
97% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED.
Largest funder’s share by year: 2020 82% · 2021 100% · 2022 100% · 2023 100% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED draws 100% of its grant income from funders outside Maryland, across 2 states in all.
Funder states come from each funder’s own filing. $271 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED's revenue grew 29% between 2017 and 2024.
this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024
Organizations like AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Maryland
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
79% of spending goes to programs.
Governance
Public support
87%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 2 states
Screen this organization
A dated, signed PDF of the compliance screen for AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED?
- AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED (Maryland) receives grants from 3 organizations whose IRS filings report $7,521 to it, the largest being VISITOR DEVELOPMENT FUND INC ($7,000). 1 of them have funded it in more than one year.
- How many funders does AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED have?
- IRS filings report 3 organizations giving $7,521 in grants to AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED, 1 of which have funded it in more than one year.
- Who is the largest funder of AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED?
- VISITOR DEVELOPMENT FUND INC is the largest funder on record, with $7,000 in grants. The full list of funders is on this page.
- How can an organization like AMERICAN SOCIETY FOR PHARMACOLOGY & EXPERIMENTAL THERAPEUTICS INCORPORATED find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Maryland. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 3 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing